Silver Book Fact

The U.S. Food and Drug Administration has approved 5 drugs for the treatment of Alzheimer’s disease. These drugs have been found to temporarily slow the worsening of Alzheimer’s symptoms for an average of 6-12 months, for around 1/2 of those individuals who take the drugs.

Alzheimer's Association. 2009 Alzheimer’s Disease Facts and Figures. Alzheimers Dement. 2009; 5(3): 234-70. http://www.alzheimersanddementia.com/article/S1552-5260(09)00074-0/fulltext

Reference

Title
2009 Alzheimer’s Disease Facts and Figures
Publication
Alzheimers Dement
Publication Date
2009
Authors
Alzheimer's Association
Volume & Issue
Volume 5, Issue 3
Pages
234-70
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Medicines Allow Patients to Remain Independent Longer: New Alzheimer’s medicine delays need for costly home care  
  • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…  
  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.  
  • Some studies have indicate that the management of high cholesterol, type 2 diabetes, high blood pressure, overweight or obesity, and other cardiovascular risk factors may help avoid or delay cognitive…  
  • A current drug in development addresses the underlying cause of type 2 diabetes by modulating genes responsible for insulin sensitization.